MoonLake Immunotherapeutics (MLTX) Exchange Rate Effect (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Exchange Rate Effect of -$483000.0 for Q1 2026, down 448.86% year-over-year from $138449.5 in Q1 2025, and down 630.77% quarter-over-quarter from $91000.0 in Q4 2025.
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$483000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 448.86% year-over-year to -$483000.0; the TTM figure through Mar 2026 stood at $714000.0 (up 12000.0% YoY), while the FY2025 annual figure was $1.1 million, up 766.41% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$483000.0, down from $91000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.4 million in Q2 2025, with the low at -$483000.0 in Q1 2026.
- The 5-year median for Exchange Rate Effect is -$6504.0 (2022), against an average of $40384.7.
- Peak annual rise in Exchange Rate Effect reached 8698.13% in 2024, while the deepest fall reached 6592.21% in 2024.
- MoonLake Immunotherapeutics' Exchange Rate Effect stood at -$8286.0 in 2022, then jumped by 872.95% to $64047.0 in 2023, then surged by 562.01% to $424000.0 in 2024, then sank by 78.54% to $91000.0 in 2025, then slumped by 630.77% to -$483000.0 in 2026.
- Business Quant data shows MLTX's Exchange Rate Effect at -$483000.0 in Q1 2026, $91000.0 in Q4 2025, and -$285000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | MoonLake Immunotherapeutics | 1.11 Bn | 572.81 Mn | - | 29,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29,000.00 |
| Mar 31, 2026 | -483,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | -285,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | -88,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Sep 30, 2024 | -325,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2023 | 64,047.00 |
| Sep 30, 2023 | 5,006.00 |
| Jun 30, 2023 | -144,518.00 |
| Mar 31, 2023 | -535.00 |
| Dec 31, 2022 | -8,286.00 |
| Sep 30, 2022 | 74,328.00 |
| Jun 30, 2022 | -50,998.00 |
| Mar 31, 2022 | -6,504.00 |
| Dec 31, 2021 | 1,873.00 |
| Sep 30, 2021 | -1,005.00 |